Yahav Achim Ve Achayot - Provident Funds Management Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Yahav Achim Ve Achayot - Provident Funds Management Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72M	Hold	10,867	–	–	1.2%	22
2026 Q1	$1.39M	Hold	10,867	–	–	2.58%	16
2025 Q4	$1.33M	Buy	+10,867	New	+$1.25M	3.04%	13
2024 Q4	–	Sell	-20,570	Closed	-$2.03M	–	23
2024 Q3	$2.03M	Hold	20,570	–	–	5.47%	6
2024 Q2	$1.91M	Hold	20,570	–	–	3.51%	10
2024 Q1	$1.95M	Hold	20,570	–	–	3.09%	8
2023 Q4	$1.84M	Hold	20,570	–	–	1.54%	14
2023 Q3	$1.53M	Hold	20,570	–	–	1.32%	16
2023 Q2	$1.71M	Hold	20,570	–	–	1.31%	17
2023 Q1	$1.54M	Hold	20,570	–	–	1.51%	20
2022 Q4	$1.7M	Hold	20,570	–	–	1.61%	17
2022 Q3	$1.62M	Hold	20,570	–	–	1.57%	19
2022 Q2	$1.51M	Hold	20,570	–	–	1.36%	22
2022 Q1	$1.83M	Hold	20,570	–	–	1.41%	20
2021 Q4	$2.33M	Hold	20,570	–	–	1.68%	20
2021 Q3	$2.59M	Buy	+20,570	New	+$2.65M	2.03%	19

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Investure LLC Charlottesville, Virginia $1.6B AUM 22.38% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Yahav Achim Ve Achayot - Provident Funds Management Company's XBI Position: Q2 2026 in Review

Yahav Achim Ve Achayot - Provident Funds Management Company held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 10,867 shares worth $1.72M. The position accounts for 1.2% of the portfolio, ranked #22.

Yahav Achim Ve Achayot - Provident Funds Management Company first reported a position in XBI in Q3 2021 and has held it in 16 quarters since. The position peaked at $2.59M in Q3 2021. 639 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Yahav Achim Ve Achayot - Provident Funds Management Company held 10,867 shares of State Street SPDR S&P Biotech ETF worth $1.72M as of Q2 2026.
Yahav Achim Ve Achayot - Provident Funds Management Company left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 1.2% of Yahav Achim Ve Achayot - Provident Funds Management Company's portfolio in Q2 2026, its #22 holding.
Yahav Achim Ve Achayot - Provident Funds Management Company first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and has held it in 16 quarters since.
Yahav Achim Ve Achayot - Provident Funds Management Company's State Street SPDR S&P Biotech ETF position peaked at $2.59M in Q3 2021.
639 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Yahav Achim Ve Achayot - Provident Funds Management Company's 13F filing for Q2 2026, filed 21 Jul 2026.